Page last updated: 2024-12-04

croton oil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators
FloraRankFlora DefinitionFamilyFamily Definition
CrotongenusA plant genus of the family EUPHORBIACEAE. The common name of dragon's blood is also used for DRACAENA and Daemonorops (ARECACEAE). Croton tiglium is the source of CROTON OIL.[MeSH]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]
Croton tigliumspecies[no description available]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]

Cross-References

ID SourceID
PubMed CID899
CHEMBL ID83479
CHEBI ID7203
SCHEMBL ID256545
SCHEMBL ID19604061
SCHEMBL ID24105621
MeSH IDM0005359

Synonyms (52)

Synonym
6-acetamido-6-deoxy-.alpha.-d-glucopyranose
smr000857252
MLS001333154
MLS001333153
8001-28-3
n-acetylchondrosamine
n-acetylhexosamine
C02711
L001205
FT-0661285
n-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
CHEMBL83479
HMS2233G11
FT-0629805
FT-0636621
FT-0629816
HMS3373E07
SCHEMBL256545
CHEBI:7203 ,
2-[1,2-13c2,15n]acetamido-2-deoxy-d-[ul-13c6]glucose
2-[1,2-13c2]acetamido-2-deoxy-d-[ul-13c6]glucose
2-acetamido-2-deoxy-d-[1-13c]galactose
2-[15n]acetamido-2-deoxy-d-[1-13c]glucose
2-acetamido-2-deoxy-d-[ul-13c6]glucose
2-[1-13c]acetamido-2-deoxy-d-glucose
HEXNAC ,
n-acetyl-hexosamine
2-acetamido-2-deoxy-hexopyranose
2-acetamido-2-deoxy-hexose
2-acetamido-2-deoxy-hexopyranoside
AKOS030212680
n-acetyl-d-man-nosamine
J-007607
SCHEMBL19604061
2-[15n]acetamido-2-deoxy-d-[ul-13c6]glucose
2-[1,2-13c2,15n]acetamido-2-deoxy-d-[1-13c]glucose
FT-0661244
Q27107455
2-acetamido-2-deoxy-d-[2-13c]glucose
2-acetamido-2-deoxy-d-[1-13c]glucose
2-[1,2-13c2]acetamido-2-deoxy-d-glucose
2-[2-13c]acetamido-2-deoxy-d-glucose
SB45257
SB47153
SB46979
SY057410
croton oil ,
DTXSID80859634
2-deoxy-2-(acetylamino)-d-glucopyranose
EN300-270189
SCHEMBL24105621
Z1509532067

Research Excerpts

Effects

ExcerptReferenceRelevance
"Croton oil has a biphasic action contracting and relaxing intestinal tissue. "( M3 muscarinic receptor- and Ca2+ influx-mediated muscle contractions induced by croton oil in isolated rabbit jejunum.
Gao, WY; Gao, Y; Hu, J; Huang, LQ; Ling, NS; Liu, CX, 2010
)
2.03
"Croton oil has a biphasic action contracting and relaxing intestinal tissue. "( M3 muscarinic receptor- and Ca2+ influx-mediated muscle contractions induced by croton oil in isolated rabbit jejunum.
Gao, WY; Gao, Y; Hu, J; Huang, LQ; Ling, NS; Liu, CX, 2010
)
2.03

Treatment

Croton oil treatment significantly elevated serum interleukin (IL)-6 concentrations and heterophil counts by 6 and 16 h postinjection. Pretreatment with Croton oil 18 hours prior to initiation with BP-4,5-epoxide also slightly enhanced the tumorigenic response in mouse skin.

ExcerptReferenceRelevance
"Croton oil treatment significantly elevated serum interleukin (IL)-6 concentrations and heterophil counts by 6 and 16 h postinjection, respectively, which returned to the basal levels of controls at 16 and 24 h, respectively."( Identification of ovotransferrin as an acute phase protein in chickens.
Balog, JM; Holt, P; Huff, GR; Huff, WE; Rath, NC; Xie, H, 2002
)
1.04
"Pretreatment with Croton oil 18 hours prior to initiation with BP-4,5-epoxide also slightly enhanced the tumorigenic response in mouse skin."( Effect of trichloropropene oxide on the ability of polyaromatic hydrocarbons and their "K-region" oxides to initiate skin tumors in mice and to bind to DNA in vitro.
Berry, DL; DiGiovanni, J; Juchau, MR; Selkirk, JK; Slaga, TJ; Viaje, A; Wilson, NM, 1977
)
0.58

Toxicity

ExcerptReferenceRelevance
" In contrast, no clear systemic side effect was observed in rats administered NM-135 at the dose producing the anti-inflammatory activity."( Local anti-inflammatory activity and systemic side effects of NM-135, a new prodrug glucocorticoid, in an experimental inflammatory rat model.
Ishii, T; Kai, H; Kakuta, T; Kibushi, N; Kijima-Suda, I; Miyata, T; Nakajima, T; Sato, C; Sugai, K; Tanaka, N, 1998
)
0.3
" gossypiifolia and to develop a safe and effective herbal gel with anti-inflammatory potential."( Development of an effective and safe topical anti-inflammatory gel containing Jatropha gossypiifolia leaf extract: Results from a pre-clinical trial in mice.
de Araujo-Junior, RF; Félix-Silva, J; Fernandes, JM; Fernandes-Pedrosa, MF; Garcia, VB; Gomes, JAS; Passos, JGR; Silva-Junior, AA; Xavier-Santos, JB; Zucolotto, SM, 2018
)
0.48
" gossypiifolia gel as a promising safe and effective topical anti-inflammatory agent for treatment of cutaneous inflammatory diseases."( Development of an effective and safe topical anti-inflammatory gel containing Jatropha gossypiifolia leaf extract: Results from a pre-clinical trial in mice.
de Araujo-Junior, RF; Félix-Silva, J; Fernandes, JM; Fernandes-Pedrosa, MF; Garcia, VB; Gomes, JAS; Passos, JGR; Silva-Junior, AA; Xavier-Santos, JB; Zucolotto, SM, 2018
)
0.48
" Possible adverse effects were evaluated after multiple treatments with the extract in a skin atrophy model."( Corticoid-like anti-inflammatory effect of Vochysia bifalcata Warm.: Preclinical evidence of efficacy and safety.
Assreuy, J; Bresolin, TMB; Cabrini, DA; Farias, IV; Ferreira, BGA; Horinouchi, CDDS; Krueger, CMA; Mendes, DAGB; Meyre-Silva, C; Otuki, MF; Soley, BDS; Zuffellato-Ribas, KC, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
" Therapeutic effect on an ascites tumor was seen using antiserum in combination with BCG or lipopolysaccharide, or less clearly with carrageenan."( Passive immunotherapy of established tumors with syngeneic antitumor serum in combination with immunopotentiators.
Mizuno, D; Shinoda, H; Yamazaki, M, 1977
)
0.26

Bioavailability

ExcerptReferenceRelevance
" Differences in time courses of the responses which were not altered by experimentally varying rate of absorption and in components of the inflammatory response to the three irritants suggest that chemicals induce skin irritation by multiple mechanisms."( Mechanisms of chemically induced skin irritation. I. Studies of time course, dose response, and components of inflammation in the laboratory mouse.
Burkhalter, A; Maibach, HI; Patrick, E, 1985
)
0.27
"The present study investigated whether MicroFluidizer Processor-based nanoemulsions of an antioxidant synergy formulation (ASF), containing delta, alpha and gamma tocopherol influenced inflammation and bioavailability in CD-1 mice."( Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties.
Kotyla, T; Kuo, F; Nicolosi, RJ; Subramanian, B; Wilson, TA; Yoganathan, S, 2008
)
0.35
" Oral Nano-cur administration inhibited such responses at doses that were eight times lower than Cur, suggesting the better bioavailability of Nano-cur compared with Cur."( Anti-inflammatory and Antioxidant Activity of Nanoencapsulated Curcuminoids Extracted from Curcuma longa L. in a Model of Cutaneous Inflammation.
Ames, FQ; Bersani-Amado, CA; Castro-Hoshino, LV; Comar, JF; Cuman, RKN; Gonçalves, OH; Leimann, FV; Lima, EP, 2021
)
0.62

Dosage Studied

Oleic acid (OA), a monounsaturated fatty acid, into Pemulen® TR2-based semisolid dosage forms. Dose-response profiles of the croton oil-induced ear edema bioassay in rats were used.

ExcerptRelevanceReference
" A dose-response relationship between the amount of acetic acid and the rate of DNA synthesis was found between the dose levels of 33 to 833 mumoles of acetic acid per application."( Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting ability.
Boutwell, RK; Bowden, GT; Slaga, TJ, 1975
)
0.25
" In the acute croton oil-induced ear edema dose-response bioassay, the topical anti-inflammatory potencies of these esters relative to prednisolone, 1, were: 8a:1."( Steroidal anti-inflammatory antedrugs: synthesis and pharmacological evaluation of 16 alpha-alkoxycarbonyl-17-deoxyprednisolone derivatives.
Choi, SJ; Khalil, MA; Kwon, T; Lee, HJ; Yoon, KJ, 1995
)
0.65
" Dose-response profiles of the croton oil-induced ear edema bioassay in rats were used to calculate the following ID50 values (nmol/ear resulting in a 50% reduction of edema): prednisolone (P), 540 nmol; 2b, 135 nmol; and 3b, 101 nmol."( New steroidal antiinflammatory antedrugs: steroidal [16 alpha,17 alpha-d]-3'-carbethoxyisoxazolines.
Heiman, AS; Kwon, T; Lee, HJ; Oriaku, ET; Yoon, K, 1995
)
0.58
" This activity displayed a dose-response relationship."( Aloe vera, hydrocortisone, and sterol influence on wound tensile strength and anti-inflammation.
Davis, RH; DiDonato, JJ; Johnson, RW; Stewart, CB, 1994
)
0.29
" The dose-response and temporal analysis of CGRP effect show that the maximal activity is present at the dose of 30 pmol/ear and when administered 30 min after the irritating agent."( Effects of CGRP in different models of mouse ear inflammation.
Amico-Roxas, M; Caruso, A; Catena Cutuli, VM; Clementi, G; de Bernardis, E; Maugeri, S; Prato, A; Scapagnini, U, 1994
)
0.29
" No dose-response relationships could be elicited with U-50488H or ICI-204448, and their antitransit effects were analogous in SS- and CO-treated animals."( Peripheral effects of opioids in a model of intestinal inflammation in mice.
Pol, O; Puig, MM; Sanchez, B, 1996
)
0.29
" From these dose-response profiles, the following ID50 values (nmol resulting in a 50% reduction of edema) were calculated: 817, 540, 266, and 67 for hydrocortisone (HC), prednisolone (P), FP16CM, and FP16CMAc, respectively."( New steroidal anti-inflammatory antedrugs: methyl 3,20-dioxo-9 alpha-fluoro-11 beta,17 alpha,21-trihydroxy-1,4-pregnadiene-16 alpha-carboxylate and methyl 21-acetyloxy-3,20-dioxo-11 beta, 17 alpha-dihydroxy-9 alpha-fluoro-1,4-pregnadiene-16 alpha-carboxyl
Chen, M; Heiman, AS; Ko, DH; Lee, HJ, 1997
)
0.3
"The anti-inflammatory effects of therapeutic dosing of drugs with greater selectivity for the inhibition of the constitutive (COX-1) or inducible isoform (COX-2) of cyclooxygenase were assessed in a model of chronic inflammation."( Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation.
Gilroy, DW; Tomlinson, A; Willoughby, DA, 1998
)
0.3
" Dose-response studies with standard contact and photocontact allergens as well as irritants and photoirritants revealed that irritants predominantly induced skin inflammation, which in turn stimulated draining lymph node cell proliferation."( An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions.
Ahr, HJ; Blümel, J; Homey, B; Lehmann, P; Ruzicka, T; Schuppe, HC; Vohr, HW; von Schilling, C, 1998
)
0.3
" From these dose-response profiles, the following ID(50) values (nmol/ear resulting in a 50% reduction of edema) were calculated: 540, 618, 454, and 346 nmol for prednisolone (P), methyl 21-desoxy-21-chloro-11beta,17alpha-dihydroxy-3,20-dioxo-1, 4-pregnadien-16alpha-carboxylate (PClCM), methyl 21-desoxy-21-chloro-11beta,17alpha-dihydroxy-9alpha-fl uoro-3, 20-dioxo-1,4-pregnadien-16alpha-carboxylate (FPClCM), and methyl 21-desoxy-21-chloro-9alpha-fluoro-11beta-hydroxy-3,20-dioxo- 1, 4-pregnadien-16alpha-carboxylate (FDPClCM), respectively."( New steroidal anti-inflammatory antedrugs: methyl 21-desoxy-21-chloro-11beta,17alpha-dihydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, methyl 21-desoxy-21-chloro-11beta-hydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, and their 9alpha-flu
Chen, M; Heiman, AS; Ko, D; Lee, HJ, 2000
)
0.31
" Dose-response curves for morphine and clonidine alone and combined at a 1:1 potency ratio were obtained, and doses producing a 50% and 60% inhibition were calculated (ED50, ED60)."( Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice.
Pol, O; Puig, MM; Warner, W, 2000
)
0.31
"In naive and tolerant mice, the combination induced linear dose-response curves up to the ED60 and then reached a plateau."( Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice.
Pol, O; Puig, MM; Warner, W, 2000
)
0.31
"1 times more potent during acute and chronic CO, and the E(max) values of the dose-response curves increased 35% during inflammation."( Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice.
Pol, O; Puig, MM; Valle, L, 2001
)
0.31
"34 and DNA index also increased after 6 weeks of treatment with CO (the dosage was increased gradually from 4 to 40 mg x L(-1))."( Direct effect of croton oil on intestinal epithelial cells and colonic smooth muscle cells.
Ding, J; Fan, DM; Jin, JP; Lan, M; Lu, J; Shi, YQ; Wang, X; Wu, HP; Wu, KC, 2002
)
0.65
" From these dose-response profiles, the following ID(50) values (nmol/ear resulting in a 50% reduction of edema) were calculated: prednisolone (Pred); 454, FP16CM; 255, 21-acetate (FP16CM-acetyl); 402, 21-propionate (FP16CM-propionyl); 474, 21-valerate (FP16CM-valeryl); 446 and 21-pivalate (FP16CM-pivalyl); 219 nmol."( New steroidal antiinflammatory antedrugs: Methyl 3,20-dioxo-9 alpha-fluoro-11 beta,17 alpha,21-trihydroxy-1,4-pregnadiene-16 alpha-carboxylate and its 21-O-acyl derivatives.
Heiman, AS; Hudson, CE; Ko, DH; Lee, HJ, 2002
)
0.31
" This study indicates that ACRH extract could be a promising skin tumor promotion suppressing agent at a lower dosage (30 mg/kg)."( Suppression of DMBA/croton oil-induced mouse skin tumor promotion by Ardisia Crispa root hexane extract.
Fezah, O; Roslida, A; Yeong, LT, 2011
)
0.69
"The present study thus demonstrates that the anti-tumor effect of the chemopreventive potential of ACRH is at a lower dosage (30 mg/kg bwt) in both the initiating and promotion period, yet it exhibits a promoting effect at a higher dosage (300 mg/kg bwt)."( Anti-tumor effect of Ardisia crispa hexane fraction on 7, 12-dimethylbenz[α]anthracene-induced mouse skin papillomagenesis.
Hamid, RA; Othman, F; Sulaiman, H; Ting, YL,
)
0.13
" The dosage of 50 μg/disk of ESL presented fairly significant zones of inhibition against Gram-positive bacteria and fungi."( Isolation, characterization and evaluation of antimicrobial and cytotoxic activity of estragole, obtained from the essential oil of Croton zehntneri (Euphorbiaceae).
Andrade, TC; Da Silva, TG; De Lima, SG; Freitas, RM; Islam, T; Militão, GC; Rocha, MS, 2015
)
0.42
"To investigate the topical anti-inflammatory effect of oleic acid (OA), a monounsaturated fatty acid, into Pemulen® TR2-based semisolid dosage forms, employing a croton oil-induced irritant contact dermatitis model in mice."( Oleic acid exhibits an expressive anti-inflammatory effect in croton oil-induced irritant contact dermatitis without the occurrence of toxicological effects in mice.
Camponogara, C; Cruz, L; Oliveira, SM; Pegoraro, NS, 2021
)
1.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-acyl-hexosamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
gemininHomo sapiens (human)Potency3.66260.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,055)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990627 (59.43)18.7374
1990's110 (10.43)18.2507
2000's142 (13.46)29.6817
2010's136 (12.89)24.3611
2020's40 (3.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.99 (24.57)
Research Supply Index7.01 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index100.46 (26.88)
Search Engine Supply Index3.09 (0.95)

This Compound (40.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (0.54%)5.53%
Reviews33 (2.99%)6.00%
Case Studies5 (0.45%)4.05%
Observational0 (0.00%)0.25%
Other1,061 (96.02%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Histological Evaluation of Peeling Induced Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin Flaps in Facelift Patients [NCT02848209]9 participants (Actual)Interventional2016-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]